论文部分内容阅读
目的探析在肝胆肿瘤治疗中采用循肝脏重要脉管精准切除术的临床价值。方法采用回顾性的分析方法将2014年8月至2016年8月于我院接受治疗的40例肝胆肿瘤患者选取为观察分析的对象,并按其手术方法的不同将其均分为两组(对照组于观察组),其中对照组予以传统肝切除手术,观察组予以精准肝切除手术,对比分析两组患者在围期手术的状况(手术时间、术中出血量、术后住院时间)以及并发症的发生情况、预后情况(复发率、生存率)。结果观察组患者的手术时间(153.50±30.25)min、术中出血量(209.10±150.10)mL、术后住院时间(240.10±80.10)min等均少于对照组的手术时间(190.85±30.65)min、术中出血量(400.25±150.35)mL、术后住院时间(385.23±80.20)min,并发症的发生率(10.00%)亦少于对照组(40.00%),且回访的调查中,其复发率(5.00%)少于对照组(35.00%),生存率(95.00%)高于对照组(65.00%);几组指标之间的比较结果均存在较大的差异(P<0.05),并均具有统计学意义。结论予以肝胆肿瘤患者行循肝脏重要脉管精准切除术,不仅可以改善患者的生存质量、生存预后,同时可以降低并发症的发生率,提高治疗安全性,具有临床推广应用的价值。
Objective To investigate the clinical value of precise hepatectomy with important blood vessels in the treatment of hepatobiliary tumors. Methods Forty hepatobiliary tumor patients treated in our hospital from August 2014 to August 2016 were retrospectively analyzed. Subjects were divided into two groups according to their surgical methods Control group in the observation group). The control group was treated by conventional hepatectomy and the observation group was given precise hepatectomy. The comparative analysis of the results of the perioperative period (operation time, intraoperative blood loss, postoperative hospital stay) The incidence of complications, prognosis (recurrence rate, survival rate). Results The operation time (153.50 ± 30.25) min, blood loss (209.10 ± 150.10) mL and postoperative hospital stay (240.10 ± 80.10) min in observation group were less than those in control group (190.85 ± 30.65) min , Blood loss (400.25 ± 150.35) mL, postoperative hospital stay (385.23 ± 80.20) min, and the incidence of complications (10.00%) were also less than those in the control group (40.00%). (5.00%) less than the control group (35.00%), the survival rate (95.00%) was higher than that of the control group (65.00%). There was a significant difference between the two groups of indicators (P <0.05) All have statistical significance. Conclusions Hepatic and gallbladder tumors can be accurately excised by vital vessels of liver, which can not only improve the quality of life and prognosis of patients, but also reduce the incidence of complications and improve the safety of treatment. It is of value in clinical application.